Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1988 Jun;100(3):455–465. doi: 10.1017/s0950268800067194

Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison

G E Dale, R M Coleman, J M Best, B B B Benetato, N C Drew, S Chinn, A O Papacosta, A J Nahmias
PMCID: PMC2249362  PMID: 2837405

Abstract

Serum and cervical secretions were collected from patients with cervical dysplasia, carcinoma-in-situ (CIS), squamous cell carcinoma (cervical SCC), and controls with normal cervices, attending clinics within the West Lambeth Health District, London. Enzyme-linked immunosorbent assays were used to examine cervical secretory IgA (sIgA) and serum IgG and IgA antibodies to herpes simplex virus (HSV). Sexual and demographic factors were considered during data analysis, which involved fitting multiple linear or multiple logistic regressions to HSV antibody levels. Prevalence of sIgA-HSV and levels of serum antibodies to HSV in all groups were compared with those of gynaecology controls. Caucasian women with mild dysplasia had a significantly higher prevalence of sIgA-HSV. Serum IgG levels to HSV (IgG-HSV) were significantly elevated in women with mild dysplasia and severe dysplasia/CIS. Serum IgA levels to HSV1 (IgG-HSV1) were significantly higher in women with cervical SCC (after adjusting for smoking habits) and other genital tumours. Significantly higher levels of serum IgA to HSV2 (IgA-HSV2) were also found among Caucasian women with cervical SCC. The possible role of HSV as a co-factor in cervical carcinogenesis is discussed.

Full text

PDF
455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coleman R. M., Pereira L., Bailey P. D., Dondero D., Wickliffe C., Nahmias A. J. Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J Clin Microbiol. 1983 Aug;18(2):287–291. doi: 10.1128/jcm.18.2.287-291.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dent P. B., Bienenstock J. Absence of IgA antibody to herpesvirus in cervicovaginal secretions of patients with carcinoma of the cervix. Clin Immunol Immunopathol. 1974 Nov;3(2):171–177. doi: 10.1016/0090-1229(74)90002-6. [DOI] [PubMed] [Google Scholar]
  3. Graham S., Rawls W., Swanson M., McCurtis J. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix. Am J Epidemiol. 1982 May;115(5):729–735. doi: 10.1093/oxfordjournals.aje.a113355. [DOI] [PubMed] [Google Scholar]
  4. Guinan M. E., Wolinsky S. M., Reichman R. C. Epidemiology of genital herpes simplex virus infection. Epidemiol Rev. 1985;7:127–146. doi: 10.1093/oxfordjournals.epirev.a036279. [DOI] [PubMed] [Google Scholar]
  5. Harris R. W., Brinton L. A., Cowdell R. H., Skegg D. C., Smith P. G., Vessey M. P., Doll R. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980 Sep;42(3):359–369. doi: 10.1038/bjc.1980.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kalimo K., Terho P., Honkonen E., Grönroos M., Halonen P. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia. Br J Obstet Gynaecol. 1981 Nov;88(11):1130–1134. doi: 10.1111/j.1471-0528.1981.tb01767.x. [DOI] [PubMed] [Google Scholar]
  7. Lycke E., Norrby R., Roos B. E. A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br J Psychiatry. 1974 Mar;124(0):273–279. doi: 10.1192/bjp.124.3.273. [DOI] [PubMed] [Google Scholar]
  8. Mendis L. N., Best J. M., Banatvala J. E. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia. Int J Cancer. 1981 May 15;27(5):669–677. doi: 10.1002/ijc.2910270514. [DOI] [PubMed] [Google Scholar]
  9. Mendis L. N., Best J. M., Senarath L., Chiphangwi J., Vestergaard B. F., Banatvala J. E. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer. Int J Cancer. 1981 Nov 15;28(5):535–542. doi: 10.1002/ijc.2910280502. [DOI] [PubMed] [Google Scholar]
  10. Nahmias A. J., Sawanabori S. The genital herpes-cervical cancer hypothesis--10 years later. Prog Exp Tumor Res. 1978;21:117–139. doi: 10.1159/000400861. [DOI] [PubMed] [Google Scholar]
  11. Pacsa A. S., Kummerländer L., Pejtsik B., Pali K. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst. 1975 Oct;55(4):775–781. doi: 10.1093/jnci/55.4.775. [DOI] [PubMed] [Google Scholar]
  12. Peltonen R. Antibodies to herpesvirus hominis types 1 and 2 among women with neoplastic change of uterine cervix. Acta Obstet Gynecol Scand. 1975;54(4):369–372. doi: 10.3109/00016347509156770. [DOI] [PubMed] [Google Scholar]
  13. Rawls W. E., Garfield C. H., Seth P., Adam E. Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer. Cancer Res. 1976 Feb;36(2 Pt 2):829–835. [PubMed] [Google Scholar]
  14. Rawls W. E., Lavery C., Marrett L. D., Clarke E. A., Adam E., Melnick J. L., Best J. M., Kraiselburd E., Benedet L. J., Brenes M. M. Comparison of risk factors for cervical cancer in different populations. Int J Cancer. 1986 Apr 15;37(4):537–546. doi: 10.1002/ijc.2910370411. [DOI] [PubMed] [Google Scholar]
  15. Seth P., Prakash S. S., Ghosh D. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India. Int J Cancer. 1978 Dec;22(6):708–714. doi: 10.1002/ijc.2910220612. [DOI] [PubMed] [Google Scholar]
  16. Treharne J. D., Darougar S., Simmons P. D., Thin R. N. Rapid diagnosis of chlamydial infection of the cervix. Br J Vener Dis. 1978 Dec;54(6):403–408. doi: 10.1136/sti.54.6.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vonka V., Kanka J., Hirsch I., Závadová H., Krcmár M., Suchánková A., Rezácová D., Broucek J., Press M., Domorázková E. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer. 1984 Jan 15;33(1):61–66. doi: 10.1002/ijc.2910330111. [DOI] [PubMed] [Google Scholar]
  18. zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet. 1982 Dec 18;2(8312):1370–1372. doi: 10.1016/s0140-6736(82)91273-9. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES